# University of Washington Med Center - Roosevelt – FDA Inspection, Feb 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/university-of-washington-med-center-roosevelt/2b916acd-a966-43c0-9e2a-6936ddd6e954
Source feed: FDA_Inspections

> FDA inspection 1307026 of University of Washington Med Center - Roosevelt, February 20, 2026. 3 citations under 21 CFR part 1271. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307026
- Company Name: University of Washington Med Center - Roosevelt
- Inspection Date: 2026-02-20
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Seattle District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1201249 - 2023-03-02
- [FDA Inspection 1056580 - 2018-06-19](https://www.keypedia.com/records/fda_inspections/university-of-washington-med-center-roosevelt/264e965e-4c05-4ff4-b03f-6ef31e69f474)
- FDA Inspection 951118 - 2015-12-09
- FDA Inspection 813811 - 2013-01-11

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kaarin-m-slotte/2960bbe1-17ba-4295-9aa8-2514a1595336)

Company: https://www.keypedia.com/companies/university-of-washington-med-center-roosevelt/9d458cdd-df60-49a3-9806-5ff488d6ee42

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913